FR2779061B1 - NOVEL METHOD FOR STABILIZING PHENOLIC COMPOUNDS AND THE PHARMACEUTICAL COMPOSITIONS THEREFROM - Google Patents

NOVEL METHOD FOR STABILIZING PHENOLIC COMPOUNDS AND THE PHARMACEUTICAL COMPOSITIONS THEREFROM

Info

Publication number
FR2779061B1
FR2779061B1 FR9804619A FR9804619A FR2779061B1 FR 2779061 B1 FR2779061 B1 FR 2779061B1 FR 9804619 A FR9804619 A FR 9804619A FR 9804619 A FR9804619 A FR 9804619A FR 2779061 B1 FR2779061 B1 FR 2779061B1
Authority
FR
France
Prior art keywords
pharmaceutical compositions
novel method
phenolic compounds
compositions therefrom
stabilizing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR9804619A
Other languages
French (fr)
Other versions
FR2779061A1 (en
Inventor
Francois Dietlin
Daniele Fredj
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PHARMATOP
Original Assignee
PHARMATOP
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PHARMATOP filed Critical PHARMATOP
Priority to FR9804619A priority Critical patent/FR2779061B1/en
Publication of FR2779061A1 publication Critical patent/FR2779061A1/en
Application granted granted Critical
Publication of FR2779061B1 publication Critical patent/FR2779061B1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
FR9804619A 1998-04-14 1998-04-14 NOVEL METHOD FOR STABILIZING PHENOLIC COMPOUNDS AND THE PHARMACEUTICAL COMPOSITIONS THEREFROM Expired - Lifetime FR2779061B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR9804619A FR2779061B1 (en) 1998-04-14 1998-04-14 NOVEL METHOD FOR STABILIZING PHENOLIC COMPOUNDS AND THE PHARMACEUTICAL COMPOSITIONS THEREFROM

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9804619A FR2779061B1 (en) 1998-04-14 1998-04-14 NOVEL METHOD FOR STABILIZING PHENOLIC COMPOUNDS AND THE PHARMACEUTICAL COMPOSITIONS THEREFROM

Publications (2)

Publication Number Publication Date
FR2779061A1 FR2779061A1 (en) 1999-12-03
FR2779061B1 true FR2779061B1 (en) 2004-08-20

Family

ID=9525206

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9804619A Expired - Lifetime FR2779061B1 (en) 1998-04-14 1998-04-14 NOVEL METHOD FOR STABILIZING PHENOLIC COMPOUNDS AND THE PHARMACEUTICAL COMPOSITIONS THEREFROM

Country Status (1)

Country Link
FR (1) FR2779061B1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110616292A (en) * 2019-04-27 2019-12-27 河北树航冶金材料有限公司 Special coated seamless solid pure calcium wire for steelmaking deoxidization and production method thereof

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPQ899400A0 (en) * 2000-07-26 2000-08-17 Csl Limited A method of stabilisation and compositions for use therein
DE102008007198A1 (en) * 2008-02-01 2009-08-13 Infectopharm Arzneimittel Und Consilium Gmbh Oral or nasally administrable formulations containing epinephrine with improved properties
FR2956815B1 (en) * 2010-02-26 2012-09-28 Delpharm Sa NOVEL PROCESS FOR THE PRODUCTION OF INJECTABLE PHLOROGLUCINOL FORM AND THE INJECTABLE FORMS THUS PRODUCED
DK3010484T3 (en) 2013-06-17 2019-08-05 Fremont Group Ltd Injectable pharmaceutical preparations comprising adrenaline and citric acid
BR112016007328A2 (en) * 2013-10-03 2017-08-01 Imprimis Pharmaceuticals Inc epinephrine-based ophthalmic compositions for intraocular administration and methods for making same
ES2770731T3 (en) 2014-08-28 2020-07-02 Sun Pharmaceutical Ind Ltd Parenteral dosage form of norepinephrine
US20170189352A1 (en) 2015-03-13 2017-07-06 Par Pharmaceutical, Inc. Epinephrine formulations
CA3034640A1 (en) 2016-08-25 2018-03-01 Imprimis Pharmaceuticals, Inc. Epinephrine-based ophthalmic compositions for intraocular administration and methods for fabricating thereof
CA3093725C (en) 2018-03-23 2021-08-24 Nevakar Inc. Epinephrine compositions and containers
FR3095122B1 (en) * 2019-04-18 2021-04-09 Crossject Pharmaceutical epinephrine solution for injection device
CN109998990B (en) * 2019-04-30 2021-12-03 遂成药业股份有限公司 Small-size epinephrine hydrochloride injection and preparation method thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4164570A (en) * 1973-09-24 1979-08-14 David Clough Stabilized aqueous catecholamine solutions
DD150694A1 (en) * 1980-04-16 1981-09-16 Gisela Raether METHOD FOR STABILIZING PHARMACEUTICAL PREPARATES WITH OXIDATING SENSITIVITIES
JPS58203910A (en) * 1982-05-20 1983-11-28 Nikken Kagaku Kk Agent for intravenous drip containing dapamine
US4664256A (en) * 1983-09-06 1987-05-12 Farmaceutisk Laboratorium Ferring A/S Packaged stable enema solution or suspension containing 5-aminosalicyclic acid
US5002973A (en) * 1987-12-28 1991-03-26 Dey Laboratories, Inc. Stabilized sulfite-free catecholamine compositions
GB9422571D0 (en) * 1994-11-09 1995-01-04 Whitehall Lab Ltd Haemorrihoidal compositions and method of use
FR2751875B1 (en) * 1996-08-05 1998-12-24 Scr Newpharm NOVEL STABLE LIQUID FORMULATIONS BASED ON PARACETAMOL AND THEIR METHOD OF PREPARATION

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110616292A (en) * 2019-04-27 2019-12-27 河北树航冶金材料有限公司 Special coated seamless solid pure calcium wire for steelmaking deoxidization and production method thereof
CN110616292B (en) * 2019-04-27 2021-03-16 河北树航冶金材料有限公司 Special coated seamless solid pure calcium wire for steelmaking deoxidization and production method thereof

Also Published As

Publication number Publication date
FR2779061A1 (en) 1999-12-03

Similar Documents

Publication Publication Date Title
HUP0102711A3 (en) Epothilone derivatives and pharmaceutical compositions containing them and process for preparation the same
HUP0201376A2 (en) Thiazoloderivatives and pharmaceutical compositions containing them and process for preparation the compounds
IL144501A0 (en) Epothilone derivatives, methods for the preparation thereof and pharmaceutical compositions containing the same
HUP0103511A3 (en) Oxazole compounds and pharmaceutical compositions containing them and process for preparation the compounds
HUP0103256A3 (en) Thiobenzimidazole derivatives and pharmaceutical compositions containing the compounds
IL133139A0 (en) Phthalamide derivatives or salts thereof as agrohorticultural insecticides and method for using the same
IL143580A0 (en) Pharmaceutical compositions containing lipophilic drugs and methods for the preparation thereof
MA26621A1 (en) COMPOSITION FOR PHARMACEUTICAL AEROSOLS
FR2779061B1 (en) NOVEL METHOD FOR STABILIZING PHENOLIC COMPOUNDS AND THE PHARMACEUTICAL COMPOSITIONS THEREFROM
EP1122311A4 (en) Remedies for neuropathy containing as the active ingredient galectin-1 or its derivatives
HUP0203496A3 (en) Novel cyclopropane derivatives, pharmaceutical compositions containing them and method for the production thereof
PL347105A1 (en) Propanolamine derivatives substituted with heterocyclic compounds, methods for their production, pharmaceutical compositions containing said compounds and the use thereof
HK1036985A1 (en) Artemisinin derivatives, method for the preparation thereof and pharmaceutical compositions containing the same
EG24463A (en) Modified release pharmaceutical composition
MA26708A1 (en) NEW INDOLE DERIVATIVE, PROCESS FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
MA23663A1 (en) PROCESS FOR THE PREPARATION OF PHARMACEUTICAL FORMULATIONS
HUP0101234A3 (en) Betha-carboline derivatives, process for their preparation and pharmaceutical compositions thereof
HUP0100277A3 (en) 2,3,4,5-tetrahydro-1h-[1,4]-benzodiazepine-3-hydroxamic acids as metalloproteinase inhibitors, process for their preparation and pharmaceutical compositions containing them
HK1040191A1 (en) Pharmaceutical composition having improved taste
FR2815346B1 (en) NOVEL AMINOTRIAZOLONE COMPOUNDS, PROCESS FOR THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
FR2776302B1 (en) NEW PROCESS FOR THE PREPARATION OF FEXOFENADINE
HUP0104544A3 (en) New pharmaceutical composition and the process for its preparation
AU5553200A (en) Process for the preparation of paroxetine and structurally related compounds
AU2882699A (en) Stabilizing composition for pharmaceutical dosage forms
AU5859799A (en) Pharmaceutical composition containing calcium valproate with delayed active substance release and method for the production of said composition